calendar
5,157 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
5,157 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
Sponsor: RenJi Hospital. Phase: NA. Conditions: Liver Cancer, Hepatocellular Carcinoma, Resistant Cancer
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Solid Tumors
Sponsor: Erasme University Hospital. Phase: . Conditions: Quality of Lifte, Cystic Fibrosis (CF), Diabetes
Sponsor: University of Colorado, Denver. Phase: . Conditions: Lung Neoplasms
Sponsor: University Hospital, Rouen. Phase: . Conditions: Eating Disorders in Adolescence
Sponsor: Ohio State University. Phase: PHASE4. Conditions: Exocrine Pancreatic Insufficiency
Sponsor: Hangzhou Endonom Medtech Co., Ltd.. Phase: NA. Conditions: Aortic Arch Aneurysm
Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: EARLY_PHASE1. Conditions: Gaucher Disease
Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Prostate Cancer
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Renal Impairment
Sponsor: Gali Perel. Phase: NA. Conditions: Cancer, Sarcopenia, Muscle Mass Loss
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: High Altitude, Hypobaric Hypoxia, Risk Reduction
Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: Eustachian Tube Dysfunction
Sponsor: Korea Institute of Radiological & Medical Sciences. Phase: . Conditions: Occupational Exposure to Radiation, Neoplasms, Radiation-Induced, Leukemia, Radiation-Induced, Radiation Effects
Sponsor: University of Gaziantep. Phase: NA. Conditions: Postoperative Pain
Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Rectal Cancer
Sponsor: ISIS Diabete Service. Phase: . Conditions: Diabetes Mellitus Type 1, Glucose Metabolism Disorder, Glycemic Control for Diabetes Mellitus, Fear of Hypoglycemia, Treatment Satisfaction, Quality of Life, Hypoglycaemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: . Conditions: Prostate Cancer
Sponsor: Xijing Hospital of Digestive Diseases. Phase: PHASE4. Conditions: Acute Severe Ulcerative Colitis
Sponsor: University of Santiago de Compostela. Phase: NA. Conditions: Gingival Irritation
Sponsor: BioGaia AB. Phase: NA. Conditions: C-Section
Sponsor: Aldeyra Therapeutics, Inc.. Phase: PHASE3. Conditions: Allergic Conjunctivitis
Sponsor: National Hepatology & Tropical Medicine Research Institute. Phase: PHASE3. Conditions: Hepatitis C, Chronic, Hepatocellular Carcinoma
Sponsor: H. Lundbeck A/S. Phase: PHASE1. Conditions: Parkinson Disease
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants
Sponsor: eleva GmbH. Phase: PHASE1. Conditions: C3 Glomerulopathy (C3G), Healthy Adult Participants
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: . Conditions: Sleep
Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: KRAS Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7
Sponsor: Henrique Tedesco. Phase: NA. Conditions: Cold Therapy
Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: FOOD ALLERGY
Sponsor: IRCCS Fondazione Stella Maris. Phase: . Conditions: Hereditary Spastic Paraplegia
Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder
Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Migraine, Central Sensitization
Sponsor: Centre Leon Berard. Phase: NA. Conditions: Cancer, Emergencies
Sponsor: Children's Hospital of Fudan University. Phase: PHASE4. Conditions: Crohn Disease, Infliximab, Immunosuppression, Children, Only
Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Newly Diagnosed Mixed Phenotype Acute Leukemia
Sponsor: Nanopath, Inc. Phase: . Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, Vaginitis, Vaginal Diseases, Genital Diseases, Female, Female Urogenital Diseases, Urogenital Disease, Candidiasis, Mycoses, Vulvovaginitis, Vulvar Diseases, Vaginosis, Bacterial
Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Elderly, Antibiotics Overuse, Viral Infections, PCR Multiplex
Sponsor: University College, London. Phase: PHASE3. Conditions: Parkinson's Disease
Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: RADICULAR PAIN
Sponsor: Artvin Coruh University. Phase: NA. Conditions: Breast Cancer
Sponsor: University of Oklahoma. Phase: NA. Conditions: Cognition, Neurovascular Coupling Mechanism and Cognitive Function, Neurovascular Control, Brain Aging, Brain Activity
Sponsor: University of Oxford. Phase: NA. Conditions: Spinal Muscular Atrophy (SMA)
Sponsor: Roswell Park Cancer Institute. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma
Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE2. Conditions: EGFR-mutant Non-small Cell Lung Cancer, Potentially Resectable
Sponsor: Daiichi Sankyo Co., Ltd.. Phase: PHASE2. Conditions: Tenosynovial Giant Cell Tumor
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Sepsis and Septic Shock
Sponsor: University Medical Centre Ljubljana. Phase: . Conditions: Fontan Circulation, Fontan Procedure